Trial / Study: 215 submissions (showing 61 to 75)

| Page 1 | Page 2 | Page 3 | Page 4 | Page 5 | Page 6 | Page 7 | Page 8 | Page 9 | Page 10 | Page 11 | Page 12 | Page 13 | Page 14 | Page 15 |

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Cannon and Dr. Gibson discuss the COGENT Trial and the limitations of observational data
Dr. Christopher P. Cannon, Dr. C. Michael Gibson, MD

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Deepak Bhatt and Dr. C. Michael Gibson discuss the results of the COGENT Trial
Dr. Deepak Bhatt, Dr. C. Michael Gibson, MD

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Deepak Bhatt and Dr. C. Michael Gibson discuss the results of the CHARISMA Genomics Substudy
Dr. Deepak Bhatt, Dr. C. Michael Gibson, MD

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. David Cohen and Dr. C. Michael Gibson discuss the TRITON-TIMI 38 Economic Substudy
Dr. David Cohen, MD, Dr. C. Michael Gibson, MD

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Junbo Ge and Dr. C. Michael Gibson discuss the results of the NO REFLOW Trial
Dr. C. Michael Gibson, MD, Dr. Ge Junbo

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Sanjay Kaul and Dr. C. Michael Gibson discuss the findings of the PLATO trial
Dr. Sanjay Kaul, Dr. C. Michael Gibson, MD

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Flavio Ribichini and Dr. C. Michael Gibson discuss the results of the CEREA-DES Trial
Dr. C. Michael Gibson, MD, Dr. Flavio Ribichini

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Josef Veselka and Dr. C. Michael Gibson discuss the STATINS PRE-PCI Trial
Dr. C. Michael Gibson, MD

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Robert Byrne and Dr. C. Michael Gibson discuss the ISAR-DESIRE 2 Trial
Dr. Robert Byrne, Dr. C. Michael Gibson

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Stephan Windecker and Dr. C. Michael Gibson discuss the results of the SIRTAX-LATE Trial from TCT 2009
Dr. C. Michael Gibson, MD

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. William Fearon and Dr. C. Michael Gibson discuss the 2-year results of the FAME Study from TCT 2009
Dr. C. Michael Gibson, , Dr. William Fearon

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Harrington and Dr. Gibson discuss the role of CRP in cardiovascular disease
Dr. Robert Harrington, Dr. C. Michael Gibson, MD

1 Star 2 Star 3 Star 4 Star 5 Star
Drs. Harrington and Gibson discuss the clinical implications of vulnerable plaque and arterial wall remodeling on CTA
Dr. Robert Harrington, MD, Dr. C. Michael Gibson

1 Star 2 Star 3 Star 4 Star 5 Star
Drs. Harrington and Gibson discuss the BARI 2D trial, factor 10a inhibitors, and the need for more sensitive bleeding me
Dr. Robert Harrington, MD, Dr. C. Michael Gibson, MD

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Matthew Price on a DES Marinade
Dr. Matthew Price